SARBODY Trademark

Trademark Overview

On Tuesday, August 9, 2016, a trademark application was filed for SARBODY with the United States Patent and Trademark Office. The USPTO has given the SARBODY trademark a serial number of 87132639. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 23, 2020. This trademark is owned by Sutro Biopharma, Inc.. The SARBODY trademark is filed in the Pharmaceutical Products category with the following description:

Therapeutic pharmaceutical preparations for the treatment of cancer or inflammatory disease
sarbody

General Information

Serial Number87132639
Word MarkSARBODY
Filing DateTuesday, August 9, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 23, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 27, 2016

Trademark Statements

Goods and ServicesTherapeutic pharmaceutical preparations for the treatment of cancer or inflammatory disease

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, August 13, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSutro Biopharma, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NameSutro Biopharma, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events

Event DateEvent Description
Monday, March 23, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, March 23, 2020ABANDONMENT - NO USE STATEMENT FILED
Wednesday, July 31, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 30, 2019EXTENSION 5 GRANTED
Thursday, July 25, 2019EXTENSION 5 FILED
Tuesday, July 30, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, July 25, 2019TEAS EXTENSION RECEIVED
Thursday, February 7, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 5, 2019EXTENSION 4 GRANTED
Tuesday, February 5, 2019EXTENSION 4 FILED
Tuesday, February 5, 2019TEAS EXTENSION RECEIVED
Wednesday, August 8, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 6, 2018EXTENSION 3 GRANTED
Monday, August 6, 2018EXTENSION 3 FILED
Monday, August 6, 2018TEAS EXTENSION RECEIVED
Monday, August 6, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, February 14, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 12, 2018EXTENSION 2 GRANTED
Monday, February 12, 2018EXTENSION 2 FILED
Monday, February 12, 2018TEAS EXTENSION RECEIVED
Saturday, August 19, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 17, 2017EXTENSION 1 GRANTED
Thursday, August 17, 2017EXTENSION 1 FILED
Thursday, August 17, 2017TEAS EXTENSION RECEIVED
Tuesday, February 21, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 27, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 27, 2016PUBLISHED FOR OPPOSITION
Wednesday, December 7, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sunday, November 20, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, November 18, 2016ASSIGNED TO EXAMINER
Saturday, August 13, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, August 12, 2016NEW APPLICATION ENTERED IN TRAM

Related Keywords

sarbody inflammatory disease cancer treatment pharmaceutical preparations therapeutic